Sustainability Home  >  Wallingford, Connecticut

Facility Information

WALLINGFORD, CONNECTICUT
WORLDWIDE MEDICINES

Facts and Figures  Top of Page

walling.gif (16760 bytes)

The Wallingford Facility is a multi-wing single building with 1,000,000 square feet dedicated to drug discovery and drug development activities within the Pharmaceutical Research Institute. The following departments are represented in Wallingford:

  • Infectious Diseases
  • Applied Biotechnology
  • Anti-cancer
  • Neuroscience
  • Combinatorial Chemistry
  • Analytical Research & Development
  • Metabolism & Pharmacokinetics
  • Clinical Research

Economic Development  Top of Page

  • The facility contributes to the local economy through employee wages and benefits and contributions through taxes.

Community and Social Progress Top of Page

  • Building on the success of the long-standing waste minimization committee, Wallingford employees established a Green Team in early 1998. The Green Team includes expanded participation from employees in research, cafeteria, facilities, EHS, administration, finance, purchasing, and lab services. The Green Team has brought forward many new ideas on implementing EHS excellence at the site. For example, the Green Team sponsored the donation of computers to schools to enhance community education.
  • Bristol-Myers Squibb is an active member of the Wallingford Local Emergency Planning Committee (LEPC). The LEPC works to ensure that the community is prepared to handle potential hazardous chemical emergencies.
  • The company continues to participate in the Meriden/ Wallingford Big Brother/ Big Sister Mentoring Program, which offers scholastic mentoring and guidance for elementary school age children who are considered educationally at risk.

Health and safety performance

  • Environmental Health & Safety training is provided as part of the new employee orientation program for all new and transferred employees. This training covers the EHS aspects for working safely at the Wallingford site including proper waste segregation and disposal. This training covers the company's commitment to safety and environmental stewardship.

Environmental Performance  Top of Page

Environmental performance

  • In 2005, employees at the Wallingford facility recycled 157 tons of office paper and cardboard, 4 tons of plastic, and 8 tons of glass.
  • In January 2004, the Wallingford facility was accepted into the U.S. Environmental Protection Agency (EPA) Performance Track program, for excellence in environmental stewardship.
  • The facility has developed a brochure (364k PDF) to help raise awareness about local threatened and endangered species. This brochure also encourages taking steps in order to protect these species.
  • The Wallingford site has initiated a mercury reduction program to reduce the use of mercury and when not possible ensure it is recycled properly. This program involves substituting non-mercury thermometers for mercury based ones, recycling all unwanted and broken mercury thermometers and fluorescent light bulbs, and secure land filling all dry cell batteries.
  • The Wallingford site is participating in the EPA Labs 21 program, which looks at ways to design in and improve the energy efficient and water consumption in research laboratories.
  • With the installation of the cogeneration (cogen) unit for both power and steam, the building of the daycare facility, the building of the E-F node, and the expansion of the materials handling building, the company is saving energy, increasing capacity for pharmaceutical research, improving safety, and enhancing flexibility for researchers.
  • The facility developed a brochure about the progress on the Sustainability 2010 goals.
  • The facility has obtained Wildlife Habitat Certification for the site.
  • The Wallingford facility supported the Connecticut Race for the Cure Walkathon, with many employees participating.
  • A new butterfly garden highlighting the endangered plant, Solidago rigida (stiff goldenrod), and other native species has been established in order to attract endangered butterfly species as well.
  • Plans to preserve a large tract of farmland hosting numerous old forest beech and oak trees covering approximately 50 acres are in the making. Extending the existing nature trail through the Butterfly Garden and this new tract will increase the trail to two miles.
  • The facility prepared and issued a stormwater management brochure to site personnel during Earth Day 2004.
  • The Wallingford facility has created a nature trail to provide a fitness walk and encourage wildlife habitat awareness. Bird boxes and bat houses have been installed and features from the farmland and apple orchard have been preserved and picnic tables added for an ideal setting for the enjoyment of the diverse local and migrant bird population.

Goals and Objectives

  • Achieve 100 percent compliance with required EHS training programs.
  • Continue to enhance the Wallingford EPA Labs 21 program for energy and water conservation.
  • Utilize the Sustainability 2010 goals Environmental Effect Analysis to develop performance targets and goals for Wallingford to reduce water consumption and nitrogen oxide emissions.

Facility Contact Information  Top of Page

+1-203-677-6000

Last updated October 27, 2006 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

 

Facility Information:

Facts and Figures

Economic Development

Community and Social Progress

Environmental Performance

Facility Contact Information

Return to List of Facilities

 

About this Report

Company profile

Pledge

Customer Information

Supplier Information

Contractor Information

Student Information

Members of the Community

Benchmarking

Awards

Glossary

Links